Clinical Trial Update: A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp) [Phase 3]

View source ↗

Summary

A Phase 3 multicenter trial evaluated the efficacy and safety of PEP005 (ingenol mebutate) gel for actinic keratoses on the face or scalp. The study is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• PEP005 (Ingenol Mebutate) Gel (Ingenol mebutate)

Snippet

Sponsor: Peplin | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED | Results posted: 2012-03-16